ASX Announcement 21 October 2026 Updated OSPREY Registry Clinical Results Presented at EANM 2026 Key highlights • Updated clinical results from the OSPREY Registry were presented on 20 October 2026 at the European Association of Nuclear Medicine (EANM) Annual Congress 2026, held in Vienna,...
Updated OSPREY Overall Survival Data Presented at EAMN
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Notice of Annual General Meeting/Proxy Form
- Application for quotation of securities - OSL
- PALACROS Officially Launched in Amsterdam
- OncoSil Clinical Data to be Presented at EANM 2026
- Notice of AGM date
Later from OncoSil Medical
- Notification of cessation of securities - OSL
- Change of Director's Interest Notice
- Peer-Reviewed Study Reports 100% Disease Control
- Annual Report (Typeset)
- Quarterly Activities/Appendix 4C Cash Flow Report
